Investment Stage

Focus Areas

About Investor

Eric Snyder is a Partner at Novo Ventures (part of Novo Holdings) in Boston, where he invests in biotech, medtech and digital health companies on behalf of the Novo Nordisk Foundation. He typically backs companies from pre-seed through later private rounds, with a personal investment range of $100K to $5.0M and a sweet spot around $1.5M, focusing on therapeutics, devices, diagnostics and healthcare platforms. Before joining Novo Ventures in 2018 he was a Managing Director at Navigant Consulting, and previously held roles at McKinsey, Pfizer, Leerink Partners and the National Institutes of Health. He holds a PhD in Neuroscience from Brown University.